Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
International Journal of Peptide and Protein Research|January 1, 1986
Characterization of cleavage products in selected human lutropin preparations. A protease-sensitive site in human lutropin beta subunitD N Ward, S D Glenn, H S Nahm, et al.Endocrinology|October 1, 1982
Isolation and characterization of hamster luteinizing hormoneS D Glenn, H S Nahm, G S Greenwald, et al.Biology of Reproduction|December 1, 1983
Estrous behavior and circadian discharge of luteinizing hormone in the prepubertal gilt in response to exogenous estrogenG D Dial, O K Dial, G W Bevier, et al.Cancer Research|February 1, 1992
Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibodyD J Buchsbaum, R L Wahl, S D Glenn, et al.Cancer Research|December 1, 1995
High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trialD M Schrier, S M Stemmer, T Johnson, et al.Cancer Research|November 1, 1990
Imaging of non-small cell lung cancers with a monoclonal antibody, KC-4G3, which recognizes a human milk fat globule antigenD G Dienhart, R F Schmelter, J L Lear, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1993
Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I studyE L Kramer, S J DeNardo, L Liebes, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trialS J DeNardo, E L Kramer, R T O'Donnell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphomaM S Kaminski, K R Zasadny, I R Francis, et al.Ethiopian Medical Journal|September 8, 2017
Mortality and Disability-Adjusted Life-Years (Dalys) for Common Neglected Tropical Diseases in Ethiopia, 1990-2015: Evidence from the Global Burden of Disease Study 2015A Deribew, B Kebede, G A Tessema, et al.Pageof 1